关于IPF未来治疗的亮点:线索和陷
Alessandro Libra1, Enrico Sciacca1, Giuseppe Muscato1
1Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, CT, Italy.
International journal of molecular sciences
|August 10, 2024
概括
异形性肺纤维化 (IPF) 是一种致命的肺痕疾病,治疗方法有限. 研究重点是分子驱动因素和新疗法,但开发有效的干预措施应对这种复杂的疾病仍然存在挑战.
科学领域:
- 肺部病理学 肺部病理学
- 病理生理学 病理生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性,不可逆转的间歇性肺病,预后不佳.
- 目前IPF的治疗选择有限,无法治愈.
- 了解IPF背后的复杂分子机制对于治疗开发至关重要.
研究的目的:
- 审查和综合最近关于驱动IPF的分子机制的研究.
- 根据当前的科学理解,讨论IPF新兴的治疗策略.
- 突出IPF研究和治疗的挑战和未来方向.
主要方法:
- 关于IPF病理生理学和治疗的最新研究的文献综述.
- 对涉及IPF进展的分子途径的分析.
- 对新兴IPF疗法的临床试验结果的评估.
主要成果:
- 尽管取得了进展,但IPF仍然是一个复杂的疾病,有效治疗方法有限.
- 一些有前途的第二阶段候选药物未能达到第三阶段试验的终点.
- 遗传,表观遗传和病理生理因素的复杂相互作用导致IPF.
结论:
- 专注于IPF分子基石的向治疗对于阻止疾病进展至关重要.
- 未来的研究应该探索个性化医学,人工智能,遗传洞察力和新药点.
- 需要综合的终点来更好地评估复杂的IPF试验中的治疗疗效.
关键词:
在IPF中,IPF是IPF.临床试验是指临床试验中的临床试验.未来的前景 未来的前景异形性肺纤维化 异形性肺纤维化分子机制的分子机制.病变的发生和发病.针对性治疗的目标疗法.治疗疗法治疗疗法治疗疗法更多相关视频
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
COPD: Pathogenesis and Clinical Features
248
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
248
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


